BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2865148)

  • 1. Beta-blockers and psychometric performance: studies in normal volunteers.
    McDevitt DG
    Eur J Clin Pharmacol; 1985; 28 Suppl():35-8. PubMed ID: 2865148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of beta-blockers on psychomotor performance in normal volunteers.
    Betts TA; Knight R; Crowe A; Blake A; Harvey P; Mortiboy D
    Eur J Clin Pharmacol; 1985; 28 Suppl():39-49. PubMed ID: 2865149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central effects of beta-adrenoceptor antagonists. I--Performance and subjective assessments of mood.
    Currie D; Lewis RV; McDevitt DG; Nicholson AN; Wright NA
    Br J Clin Pharmacol; 1988 Aug; 26(2):121-8. PubMed ID: 2905148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diazepam/beta-adrenoceptor antagonist interactions.
    Hawksworth G; Betts T; Crowe A; Knight R; Nyemitei-Addo I; Parry K; Petrie JC; Raffle A; Parsons A
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):69S-76S. PubMed ID: 6146341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cetamolol: cardiovascular effects of a new cardioselective beta-adrenoceptor blocker possessing partial agonistic activity and lacking membrane-stabilizing activity.
    Beaulieu G; Grimes D; Muirhead C; Oshiro G
    Can J Physiol Pharmacol; 1984 Jun; 62(6):610-6. PubMed ID: 6146394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta-2 Adrenergic blockade evaluated with epinephrine after placebo, atenolol, and nadolol.
    Hiatt WR; Wolfel EE; Stoll S; Nies AS; Zerbe GO; Brammell HL; Horwitz LD
    Clin Pharmacol Ther; 1985 Jan; 37(1):2-6. PubMed ID: 2856902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic profile of bisoprolol, a new beta 1-selective adrenoceptor antagonist.
    Leopold G; Ungethüm W; Pabst J; Simane Z; Bühring KU; Wiemann H
    Br J Clin Pharmacol; 1986 Sep; 22(3):293-300. PubMed ID: 2876722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central effects of beta-adrenoceptor antagonists. II--Electroencephalogram and body sway.
    Nicholson AN; Wright NA; Zetlein MB; Currie D; McDevitt DG
    Br J Clin Pharmacol; 1988 Aug; 26(2):129-41. PubMed ID: 2905149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifibrillatory properties of the beta-adrenergic receptor antagonists, nadolol, sotalol, atenolol and propranolol, in the anesthetized dog.
    Patterson E; Lucchesi BR
    Pharmacology; 1984; 28(3):121-9. PubMed ID: 6144114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cardioselective beta blockade on the peripheral lung in guinea pigs.
    Clerici C; Macquin-Mavier I; Harf A
    Eur Respir J; 1988 Jan; 1(1):10-4. PubMed ID: 2896599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Atenolol, its cardioselective property for adrenergic beta-receptor blocking action and effect on the cardiac function (author's transl)].
    Kanno M; Nakaya H; Hattori Y; Izumi T; Nishimura T; Sakai K; Abiko Y
    Nihon Yakurigaku Zasshi; 1980 Oct; 76(7):621-32. PubMed ID: 6111522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of beta-adrenoceptor blockers on mitochondrial ATPase activity in guinea pig heart preparations.
    Almotrefi AA; Dzimiri N
    Eur J Pharmacol; 1992 May; 215(2-3):231-6. PubMed ID: 1356792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central effects of beta-adrenoceptor antagonists.
    Salem SA; McDevitt DG
    Clin Pharmacol Ther; 1983 Jan; 33(1):52-7. PubMed ID: 6848299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of conventional B-blockers and nebivolol on psychomotor performances in healthy volunteers: a preliminary report.
    Kumar A; Khajuria V; Tandon VR; Kapoor B; Singh R
    Indian J Physiol Pharmacol; 2007; 51(2):183-8. PubMed ID: 18175665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-adrenoceptor blockade and hypoglycaemia. A randomised, double-blind, placebo controlled comparison of metoprolol CR, atenolol and propranolol LA in normal subjects.
    Kerr D; MacDonald IA; Heller SR; Tattersall RB
    Br J Clin Pharmacol; 1990 Jun; 29(6):685-93. PubMed ID: 1974143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-adrenergic antagonist inhibition of hepatic 3,5,3'-triiodothyronine production.
    Shulkin BL; Peele ME; Utiger RD
    Endocrinology; 1984 Sep; 115(3):858-61. PubMed ID: 6146516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of betaxolol, propranolol, and atenolol on isoproterenol-induced beta-adrenoceptor responses.
    Riddell JG; Shanks RG
    Clin Pharmacol Ther; 1985 Nov; 38(5):554-9. PubMed ID: 2865028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of selective beta 2-adrenoceptor blockade on serum potassium and exercise performance in normal men.
    Gullestad L; Birkeland K; Nordby G; Larsen S; Kjekshus J
    Br J Clin Pharmacol; 1991 Aug; 32(2):201-7. PubMed ID: 1681847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade.
    McDevitt DG; Brown HC; Carruthers SG; Shanks RG
    Clin Pharmacol Ther; 1977 May; 21(5):556-66. PubMed ID: 15753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
    Pringle TH; O'Connor PC; McNeill AJ; Finch MB; Riddell JG; Shanks RG
    Br J Clin Pharmacol; 1986 Mar; 21(3):249-58. PubMed ID: 2870732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.